GB1078939A - Diagnostic reagent - Google Patents

Diagnostic reagent

Info

Publication number
GB1078939A
GB1078939A GB5168864A GB5168864A GB1078939A GB 1078939 A GB1078939 A GB 1078939A GB 5168864 A GB5168864 A GB 5168864A GB 5168864 A GB5168864 A GB 5168864A GB 1078939 A GB1078939 A GB 1078939A
Authority
GB
United Kingdom
Prior art keywords
hcg
antibody
diagnostic reagent
animal
drop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5168864A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB1078939A publication Critical patent/GB1078939A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A diagnostic reagent, suitable for pregnancy determination by agglutination with human chorionic gonadotropin (HCG), comprises an antibody for HCG adsorbed on the surface of polystyrene particles which are in suspension and have an average diameter of 0.15-0.60 microns. The antibody may be first formed by injecting an animal with HCG, subsequently bleeding the animal and recovering the elaborated antibody from the blood. By mixing a drop of urine with a drop of reagent, pregnancy is indicated by visible agglutination in 30-60 secs.
GB5168864A 1964-08-12 1964-12-18 Diagnostic reagent Expired GB1078939A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38917764A 1964-08-12 1964-08-12
US47899965A 1965-08-11 1965-08-11

Publications (1)

Publication Number Publication Date
GB1078939A true GB1078939A (en) 1967-08-09

Family

ID=27012580

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5168864A Expired GB1078939A (en) 1964-08-12 1964-12-18 Diagnostic reagent
GB4451865A Expired GB1086478A (en) 1964-08-12 1965-10-20 Anti-protein to human chorionic gonadotrophin

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4451865A Expired GB1086478A (en) 1964-08-12 1965-10-20 Anti-protein to human chorionic gonadotrophin

Country Status (2)

Country Link
BE (1) BE684708A (en)
GB (2) GB1078939A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353858A1 (en) * 1976-06-01 1977-12-30 Warner Lambert Co PREGNANCY TEST BY DIRECT AGGLUTINATION
FR2366569A1 (en) * 1976-09-29 1978-04-28 Mochida Pharm Co Ltd IMMUNOCHEMICAL PROCESS AND REAGENTS FOR THE DOSAGE OF HAPTENE

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310508A (en) * 1979-06-19 1982-01-12 Siber George Diagnostic test and reagent therefor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353858A1 (en) * 1976-06-01 1977-12-30 Warner Lambert Co PREGNANCY TEST BY DIRECT AGGLUTINATION
FR2366569A1 (en) * 1976-09-29 1978-04-28 Mochida Pharm Co Ltd IMMUNOCHEMICAL PROCESS AND REAGENTS FOR THE DOSAGE OF HAPTENE

Also Published As

Publication number Publication date
BE684708A (en) 1967-01-30
GB1086478A (en) 1967-10-11

Similar Documents

Publication Publication Date Title
GB1294463A (en) Immunological reagent and process for making same
NL158937B (en) METHOD FOR DETERMINATION OF A PROTEIN OR POLYPEPTIDE IN AN Aqueous SAMPLE BY REACTION WITH ANTIBODIES AND A REAGENT PACKAGE FOR PERFORMING THESE ASSAYS.
DE69031561T2 (en) IMPROVED IMMUNOTESTING METHOD CONTAINING A MIXTURE OF LYOPHILIZED REAGENTS
GB1143938A (en) Immunochemical reagents and process for their manufacture
ES453609A1 (en) Direct agglutination test for pregnancy
GB1083683A (en) Diagnostic agents
ES454276A1 (en) Pregnancy test device
GB1036592A (en) Reagents
SE8404250L (en) ANTI-PREGNANCY TESTING AND CONTRACEPTIVE VACCIN
ES444543A1 (en) Immunological reagent and method of using same
GB1078939A (en) Diagnostic reagent
KR830005863A (en) Method of producing human chorionic gonadotropin
FI44720C (en) Reagents for the determination of human chorionic gonadotropin (HCG) in urine.
GB987784A (en) A process for the separation of protein antigens from protein mixtures and the production of antisera therefor
ES405388A1 (en) Diagnostic reagents test method and pack
IL42612A0 (en) Specific antiserum and method for radioimmunoassay of human chorionic gonadotropin in the presence of luteinizing hormone
ES284276A1 (en) An immune method for the diagnosis of pregnancy (Machine-translation by Google Translate, not legally binding)
GB1509284A (en) Method for use in the determination of the concentration of luteinizing hormone(lh)
GB1155365A (en) Immunological Reaction
ATE144147T1 (en) INTERACTION SYSTEM CONTAINING A DISPERSED AQUEOUS PHASE CONTAINING AN ANTIBODIES OR ANTIBODY FRAGMENT STABILIZED WITH A SURFACE-ACTIVE SUBSTANCE
GB1530942A (en) Method for the determination of pregnancy and a serodiagnostic composition therefor
GB1061908A (en) Improvements in the production of human chorionic gonadotropin antibody
Breg et al. Identification of human translocation chromosomes by quinacrine fluorescence patterns
Greensher et al. Screening of newborns for sex chromosomal abnormalities by a fluorescent technique
Matsumura et al. Studies on congenital sensitization. 1. Detection of food antigens and antibodies in the maternal serum, umbilical cord serum, the serum and the 1st voided urine of newborn infants, amniotic fluid and meconium